Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · IEX Real-Time Price · USD
58.00
+4.97 (9.37%)
At close: Jul 19, 2024, 4:00 PM
59.50
+1.50 (2.59%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
CRBP Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CRBP stock have an average target of 74.6, with a low estimate of 46 and a high estimate of 85. The average target predicts an increase of 28.62% from the current stock price of 58.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CRBP stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 3 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +37.93% | Jul 22, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $80 | Buy | Reiterates | $80 | +37.93% | Jul 10, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $85 | Strong Buy | Initiates | $85 | +46.55% | Jun 26, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $77 → $82 | Buy | Maintains | $77 → $82 | +41.38% | Jun 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 → $80 | Buy | Maintains | $60 → $80 | +37.93% | Jun 3, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
3.40M
EPS This Year
-5.43
from -10.31
EPS Next Year
-5.08
from -5.43
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 10.5M | 26.3M | 26.3M | 89.1M |
| Avg | n/a | 3.4M | 8.5M | 8.5M | 45.8M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 672.1% | 208.8% | 948.1% |
| Avg | - | - | 150.0% | - | 439.4% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -4.47 | -3.50 | -4.02 | -3.60 | -6.63 |
| Avg | -5.43 | -5.08 | -8.62 | -9.18 | -14.64 |
| Low | -6.85 | -6.34 | -14.19 | -14.54 | -29.34 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.